04/08/2025
Exciting Announcement from Oticon Medical: Introducing the Sentio™ System.
Oticon Medical is delighted to announce the launch of our first active transcutaneous bone conduction hearing system, the Sentio System. Sentio System delivers the proven benefits of the Ponto™ System and more, in a transcutaneous option. It consists of the Sentio 1 Mini external sound processor and Sentio Ti Implant, which is placed under the skin. It is the smallest transcutaneous system available to date*.
“With the launch of Sentio System, we provide best-in-class and the smallest active transcutaneous system. More importantly, Oticon Medical now offers a complete portfolio of bone-anchored hearing systems. This portfolio meets the needs of patients and customers, and fits diverse clinical settings and global reimbursement schemes for the treatment. We strongly believe that offering a broad portfolio is the path to achieving our mission to "Help more people" and give more potential users the quality of life improvements these systems offer”, says René Govaerts, President & General Manager, Oticon Medical.
Discover more about the Sentio System: https://sentio.oticonmedical.com/au
* Sentio implant and sound processor physical features and comparison to other devices (Doc-00123204)
Not all products are available in all markets. Product availability and indications are subject to regulatory approval and may vary depending on the market. This medical device must be administered/ applied/implanted by a healthcare professional and not available for purchase by the general public.